GSK3B and osteosarcoma: Mechanistically, CGREF1 enhances Cyclin D expression by modulating GSK3β/β-catenin signaling within the Wnt pathway, thereby promoting the transition of osteosarcoma cells from G1/G0 to S phase and facilitating their proliferation (Fig. 8).